Laos Element Pharmaceuticals’ sotorasibu is the first generation targeted drug

Sotoraxib (AMG510) is a third-generation tyrosine kinase inhibitor currently on the market in Laos. Sotorasiib is used to treat non-small cell lung cancer that is advanced or has spread to other parts of the body after treatment with at least one cancer drug (metastatic).

Before taking sotoracib, tell your doctor if a patient is allergic to sotoracib , any other medicine, or any ingredient in sotoracib tablets. Tell me about other prescription and over-the-counter medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change your medication dosage or carefully monitor for side effects. The following over-the-counter or herbal products may interact with sotolacil: Cimetidine(TagametHB), esomeprazole(Nexium), famotidine, be sure to let your doctor know you are taking these medicines. If the patientis taking sotorracibwith an antacid, take sotorracib 4 hours before or 10 hours after taking the antacid. Tell your doctor if you have or have ever had liver disease, or lung or respiratory disease other than lung cancer. Tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while takingsotoraxib , please contact your doctor. Tell your doctor if you are breast-feeding or plan to breast-feed and you should not breast-feed during treatment with sotoraxiband for 1weeks after the last dose. Laos Element Pharmaceuticals Retail price120mg56 tablets sell for more than 2 more than one thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.